Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New parent sleep program shows promise for better rest and mood

NCT ID NCT06143917

Symptom relief Sponsor: Taipei Veterans General Hospital, Taiwan Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a special sleep program for new parents and their babies. The program included sleep education, relaxation training, and support. Researchers wanted to see if it could improve sleep, mental health, and infant health. The study involved 306 parents and their newborns.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

306 people

The number who actually took part.

Started

Feb 2024

Finished

May 2025

Lead sponsor

A government agency

The lead sponsor is a government body.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 60 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Postpartum women aged 18 years or older. * Postpartum women with a singleton pregnancy, and the gestational age of their infant is at least 32 weeks. * Postpartum women with a severe insomnia severity index score of ≥8 points. * Postpartum women and their husbands or partners capable of reading, understanding, and communicating in Mandarin. * Postpartum women and their husbands or partners with internet access and the ability to operate resources using a smartphone, tablet, or computer. * Both postpartum women and their husbands or partners are willing to participate in the research process. Exclusion Criteria: * Postpartum women diagnosed with Insomnia Disorder, Anxiety Disorders, or Depression. * Postpartum women suffering from arrhythmia or cardiovascular diseases. * Postpartum women working in shifts. * Infants with congenital abnormalities, neurological impairments (such as hydrocephalus, periventricular leukomalacia), requiring the use of tubes or respirators after discharge, or using medications that might affect sleep (such as caffeine, sedatives, muscle relaxant, anti-epileptic drugs, or pain medications).

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Infant health are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

insomnia Psychological Well-Being

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Infant health Psychological health Sleep quality

Contacts and locations

Locations

  • Taipei Veterans General Hospital

    Taipei, Taiwan

More trials for these conditions

Other studies related to the condition(s) this trial covers.